Evidence map›Paper›PMID 41518435›Full record

ArticleApoptosis : an international journal on programmed cell death2026

RNF168 promotes chronic colitis through ANXA7-mediated autophagy and NLRP3-driven pyroptosis.

Honggang Wang, Yujun Liu, Wenliang Jiang, Yun Ji, Shaoqi Cheng, Chao Cheng, Ziwei Xu, Changhe Zhang, Jing Sun, Jie Zhao

Abstract read
PubMed Publisher
In one paragraph

Article in Apoptosis : an international journal on programmed cell death, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Honggang Wang *Department of General Surgery, Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, People's Republic of China.
Yujun Liu *Department of General Surgery, Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, People's Republic of China.
Wenliang Jiang *Department of General Surgery, Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, People's Republic of China.
Yun Ji *Department of Gastroenterology, Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, People's Republic of China.
Shaoqi ChengDepartment of General Surgery, Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, People's Republic of China.
Chao ChengDepartment of General Surgery, Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, People's Republic of China.
Ziwei XuDepartment of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
Changhe ZhangDepartment of General Surgery, Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, People's Republic of China. 15852965000@163.com.
Jing SunDepartment of Gastroenterology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, People's Republic of China. sunjing9002@njmu.edu.cn.
Jie ZhaoDepartment of Gastrointestinal Surgery, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, The Third Affiliated Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, Changzhou, People's Republic of China. zhaojie@njmu.edu.cn.

Funding

Changzhou Medical Center of Nanjing Medical University Program CMC2024PY17Changzhou Sci&Tech Program 2022CZBJ066, CJ20245024National Natural Science Foundation of China 82300609Taizhou School of Clinical Medicine, Nanjing Medical University TZKY20230308, TZKY20230102Yanzhen Talent Program for Emerging Academic Leaders YZ-HBDTR-SJ-2025
6 · The paper itself

Abstract

This study aimed to investigate the roles of ANXA7 and its upstream regulator RNF168 in Crohn's disease (CD) progression, focusing on their interaction with inflammation and intestinal mucosal barrier disruption. Colon tissues from CD patients, including inflamed and uninflamed tissues, were analyzed to assess ANXA7 expression. The biological functions of ANXA7 were studied in vitro using LPS/ATP-stimulated NCM460 cells, employing ANXA7 knockdown and overexpression experiments. Protein-protein interactions were examined using co-immunoprecipitation (Co-IP) and mass spectrometry. The regulatory role of RNF168 in ANXA7 degradation was explored through Co-IP and ubiquitination assays. The effects of RNF168 and ANXA7 on autophagy and NLRP3 inflammasome-induced pyroptosis were assessed. In vivo experiments were conducted using IL-10 knockout (KO) mice, RNF168

Indexed as

AutophagyColitisCrohn DiseaseNLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisUbiquitin-Protein LigasesAnimalsChronic DiseaseHumansInflammasomesMaleMiceMice, Inbred C57BLMice, KnockoutUbiquitinationInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanUbiquitin-Protein LigasesAutophagyCrohn’s diseaseELK1/RNF168/ANXA7 axisPyroptosisUbiquitination

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.